16,400 resources
Start Prev Rows 14000 - 14200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date |
---|---|---|---|---|---|---|---|
hl7.fhir.us.mdi | R4 | ValueSet/vs-med-dq-review | Medical Data Quality Review | trial-use | 3 | pher | 2025-07 |
hl7.fhir.us.mdi | R4 | ValueSet/vs-per-dq-review | Personal Data Quality Review | trial-use | 3 | pher | 2025-07 |
hl7.fhir.us.mdi | R4 | ValueSet/vs-dcr-reason | Death Certificate Review Reason | trial-use | 3 | pher | 2025-07 |
hl7.fhir.us.mdi | R4 | ValueSet/vs-signature-status | Signature Status | trial-use | 3 | pher | 2025-07 |
hl7.fhir.us.mdi | R4 | ValueSet/vs-me-cert-affirmation | Medical Examiner Certification Status | trial-use | 3 | pher | 2025-07 |
hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-pharmacy-type | RTPBC Pharmacy Type Value Set | active | 2020-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1123 | COVID_19 (Disorders) (ICD10CM) | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1124 | COVID_19 (Disorders) (SNOMED) | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1142 | COVID_19 (Tests for SARS_CoV_2 Nucleic Acid) | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1143 | COVID_19 (Organism or Substance in Lab Results) | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1158 | COVID_19 (Tests for SARS_CoV_2 Antigen) | active | 2024-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1409 | COVID_19 (Tests for SARS_CoV_2 Genomic Sequence) | active | 2025-02 | ||
hl7.fhir.us.specialty-rx | R4 | ValueSet/specialty-rx-task-input-type | Specialty Rx Value Set - Task Input Type | active | 2023-01 | ||
hl7.fhir.us.specialty-rx | R4 | ValueSet/specialty-rx-task-output-type | Specialty Rx Value Set - Task Output Type | active | 2023-01 | ||
hl7.fhir.us.specialty-rx | R4 | ValueSet/specialty-rx-task-type | Specialty Rx Value Set - Task Type | active | 2023-01 | ||
hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-error-code | RTPBC Error Code Value Set | active | 2020-05 | ||
hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-billing-unit | RTPBC Billing Unit Value Set | active | 2020-05 | ||
hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-state-and-province-code | RTPBC Two Letter State and Province Code Value Set | active | 2020-05 | ||
signal.core.r4 | R4 | ValueSet/fips-county-co | CO FIPS Counties | draft | 2023-06 | ||
signal.core.r4 | R4 | ValueSet/diagnosis-role | DiagnosisRole | draft | vocab | 2019-10 | |
signal.core.r4 | R4 | ValueSet/encounter-diet | Diet | draft | 1 | pa | 2019-10 |
signal.core.r4 | R4 | ValueSet/encounter-admit-source | Admit source | draft | pa | 2019-10 | |
signal.core.r4 | R4 | ValueSet/encounter-participant-type | Participant type | trial-use | 3 | pa | 2019-10 |
signal.core.r4 | R4 | ValueSet/encounter-special-courtesy | Special courtesy | draft | pa | 2019-10 | |
signal.core.r4 | R4 | ValueSet/encounter-special-arrangements | Special arrangements | draft | pa | 2019-10 | |
signal.core.r4 | R4 | ValueSet/referencerange-meaning | Observation Reference Range Meaning Codes | trial-use | 0 | oo | 2019-10 |
signal.core.r4 | R4 | ValueSet/referencerange-appliesto | Observation Reference Range Applies To Codes | draft | 1 | oo | 2019-10 |
signal.core.r4 | R4 | ValueSet/service-type | Service type | draft | 1 | pa | 2019-10 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/BreastImagingReportTypesVS | Breast Imaging Report Types ValueSet | active | 2022-12 | ||
signal.core.r4 | R4 | ValueSet/questionnaire-dacods-marital-status | Questionnaire DACODS Marital Status | draft | 1 | pa | |
hl7.fhir.us.qicore | R4 | ValueSet/qicore-negation-reason | QICore Negation Reason Codes | trial-use | 4 | cqi | 2018-12 |
signal.core.r4 | R4 | ValueSet/signal-program | Signal Program | draft | 1 | pa | |
hl7.fhir.us.qicore | R4 | ValueSet/qicore-positive-event-status | Positive Event Status | trial-use | 4 | cqi | 2018-12 |
hl7.fhir.us.qicore | R4 | ValueSet/qicore-positive-medication-admin-status | Positive MedicationAdministration Status | trial-use | 4 | cqi | 2018-12 |
hl7.fhir.us.qicore | R4 | ValueSet/qicore-positive-medicationdispense-status | Positive MedicationDispense Status | trial-use | 4 | cqi | 2018-12 |
hl7.fhir.us.qicore | R4 | ValueSet/qicore-positive-medicationrequest-status | Positive MedicationRequest Status | trial-use | 4 | cqi | 2018-12 |
hl7.fhir.us.qicore | R4 | ValueSet/qicore-positive-request-status | Positive Request Status | trial-use | 4 | cqi | 2018-12 |
hl7.fhir.us.qicore | R4 | ValueSet/qicore-positive-task-status | Positive Task Status | trial-use | 4 | cqi | 2018-12 |
hl7.fhir.us.carin-bb | R4 | ValueSet/CMSMS3MAPAPRDRG | MS-DRGs - AP-DRGs - APR-DRGs Value Set | trial-use | fm | 2025-02 | |
signal.core.r4 | R4 | ValueSet/us-core-usps-state | USPS Two Letter Alphabetic Codes | active | 2022-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.2000.1 | Percutaneous Coronary Intervention ICD10 | active | 2018-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.2000.2 | Percutaneous Coronary Intervention SNOMEDCT | active | 2024-08 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.2000.3 | Percutaneous Coronary Intervention CPT | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.2000.4 | Percutaneous Coronary Intervention HCPCS | active | 2018-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.1.11.10901 | ParticipationType | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1221.193 | Gender Dysphoria | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1221.194 | Gender Identity | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.335 | Sleep Apnea | active | 2018-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.99 | Gestational Diabetes | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.4.642.3.155 | Care Team Category | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.526.2.169 | Cardiac Surgery | active | 2025-01 | ||
hl7.fhir.us.core | R4 | ValueSet/us-core-diagnosticreport-report-and-note-codes | US Core Non Laboratory Codes | trial-use | 3 | cgp | 2022-09 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.526.2.1064 | Neurobehavioral Status Exam (CPT) | active | 2019-03 | ||
signal.core.r4 | R4 | ValueSet/coverage-class | Coverage Class Codes | trial-use | 2 | fm | 2019-10 |
signal.core.r4 | R4 | ValueSet/coverage-financial-exception | Example Coverage Financial Exception Codes | draft | 1 | fm | 2019-10 |
hl7.fhir.us.carin-bb | R4 | ValueSet/C4BBSurfaceCodes | US Surface Codes Set Value Set | trial-use | fm | 2025-02 | |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-sensory-functions-pain-clinical-test-vs | Personal Functioning and Engagement Sensory Functions and Pain Clinical Test Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-goals-self-care-vs | Personal Functioning and Engagement Goals Self-Care Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-goals-mobility-vs | Personal Functioning and Engagement Goals Mobility Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-learning-and-applying-knowledge-vs | Personal Functioning and Engagement Learning and Applying Knowledge Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-self-care-vs | Personal Functioning and Engagement Self-Care Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-body-structures-vs | Personal Functioning and Engagement Body Structures Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-communication-vs | Personal Functioning and Engagement Communication Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-functions-of-digestive-vs | Personal Functioning and Engagement Functions Of Digestive, Metabolic, and Endocrine Systems Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-domestic-life-vs | Personal Functioning and Engagement Domestic Life Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-genitourinary-vs | Personal Functioning and Engagement Genitourinary and Reproductive Functions Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-mental-functions-vs | Personal Functioning and Engagement Mental Functions Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-mobility-vs | Personal Functioning and Engagement Mobility Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-neuromusculoskeletal-vs | Personal Functioning and Engagement Neuromusculoskeletal and Movement Related Functions Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-sensory-functions-pain-vs | Personal Functioning and Engagement Sensory Functions and Pain Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-skin-functions-vs | Personal Functioning and Engagement Functions of Skin and Related Structures Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-structures-voice-and-speech-vs | Personal Functioning and Engagement Structures Involved in Voice and Speech Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-voice-and-speech-vs | Personal Functioning and Engagement Voice and Speech Functions Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-products-and-technology-vs | Personal Functioning and Engagement Products and Technology Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-goals-panel-vs | Personal Functioning and Engagement Goals Panel Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-panel-vs | Personal Functioning and Engagement Panel Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.davinci-cdex | R4 | ValueSet/cdex-loinc-attachment-codes | CDex LOINC Attachment Codes Value Set | trial-use | 2 | claims | 2022-06 |
hl7.fhir.us.davinci-pas | R4 | ValueSet/pas-loinc-attachment-codes | PAS LOINC Attachment Codes Value Set | trial-use | 3 | fm | 2022-06 |
hl7.fhir.us.carin-bb | R4 | ValueSet/C4BBProfessionalAndNonClinicianClaimSubType | C4BB Professional And Non Clinician Claim SubType Value Set | trial-use | fm | 2025-02 | |
hl7.fhir.us.carin-bb | R4 | ValueSet/C4BBProfessionalAndNonClinicianClaimType | C4BB Professional And Non Clinician Claim Type Value Set | trial-use | fm | 2025-02 | |
signal.core.r4 | R4 | ValueSet/fm-status | Financial Resource Status Codes | draft | 2 | fm | 2019-10 |
hl7.fhir.us.qicore | R4 | ValueSet/qicore-medication-dose-type | QICore SNOMED CT Dosage Codes | trial-use | 4 | cqi | 2018-08 |
hl7.fhir.us.insurance-card | R4 | ValueSet/C4DICContactTypeVS | C4DIC Contact Type | active | claims | 2024-04 | |
hl7.fhir.us.insurance-card | R4 | ValueSet/C4DICCopayTypeVS | C4DIC Copay Type | active | claims | 2024-04 | |
hl7.fhir.us.insurance-card | R4 | ValueSet/C4DICCoverageClassVS | C4DIC Coverage Class | active | claims | 2024-04 | |
signal.core.r4 | R4 | ValueSet/subscriber-relationship | SubscriberPolicyholder Relationship Codes | trial-use | 2 | fm | 2019-10 |
hl7.fhir.us.pacio-pfe | R4 | ValueSet/pfe-category-vs | Personal Functioning and Engagement Category Value Set | trial-use | 3 | pc | 2025-07 |
hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-prescribable-product-code | RTPBC Prescribable Product Code Value Set | active | 2020-05 | ||
signal.core.r4 | R4 | ValueSet/languages | Common Languages | draft | 5 | fm | 2016-08 |
signal.core.r4 | R4 | ValueSet/coverage-copay-type | Coverage Copay Type Codes | trial-use | 2 | fm | 2019-10 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.146 | Buprenorphine | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.166 | Codeine Schedule II and III | active | 2023-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.167 | Alfentanil | active | 2021-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.168 | Remifentanil | active | 2021-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.169 | Sufentanil | active | 2021-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1125.1 | Schedule IV Benzodiazepines | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1002.11 | Oxycodone | active | 2023-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1002.12 | Oxymorphone | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1002.70 | Morphine | active | 2024-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1002.71 | Methadone Medications | active | 2021-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1002.72 | Meperidine | active | 2024-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1002.73 | Levorphanol | active | 2021-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1002.74 | Hydromorphone | active | 2021-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1002.75 | Hydrocodone | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1002.76 | Fentanyl | active | 2024-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1004.12 | Butorphanol | active | 2021-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1004.15 | Opium Combinations | active | 2024-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1004.16 | Pentazocine | active | 2024-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1004.17 | Tapentadol | active | 2021-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1004.18 | Tramadol | active | 2024-02 | ||
hl7.fhir.us.mihr | R4 | ValueSet/hypertensive-disorders-pregnancy-ICD | ValueSet – Hypertensive Disorders of Pregnancy ICD | draft | 2023-03 | ||
hl7.fhir.us.mihr | R4 | ValueSet/hypertensive-disorders-pregnancy-SNOMED | ValueSet – Hypertensive Disorders of Pregnancy SNOMED CT | draft | 2023-03 | ||
hl7.fhir.us.eltss | R4 | ValueSet/eltss-observation-code | Observation Code Value Set | informative | hsswg | 2019-09 | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.11.20.9.69.6 | Planned or Completed moodCode | active | 2024-06 | ||
hl7.fhir.us.pacio-toc | R4 | ValueSet/toc-loinc-answered-by-LL5571-6-vs | Transitions of Care LOINC Terms Answered by LL5571-6 Answer List Value Set | trial-use | 2 | pc | 2025-06 |
hl7.fhir.us.pacio-toc | R4 | ValueSet/toc-del-loinc-vs | Transitions of Care DEL LOINC Terms Value Set | trial-use | 2 | pc | 2025-06 |
hl7.fhir.us.pacio-toc | R4 | ValueSet/toc-del-loinc-answered-by-LL5571-6-vs | Transitions of Care LOINC Terms Included in the DEL Answered by LL5571-6 Answer List Value Set | trial-use | 2 | pc | 2025-06 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1099.28 | Problem Type (LOINC) | active | 2023-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.11.20.9.39 | Result Status | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1078.476 | Allergy To Vaccine Component | active | 2023-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.2 | InstructionActStatus | active | 2017-11 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.11.20.9.69.7 | Obligation or Prohibition Instruction Type | active | 2017-11 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.58 | Findings Related to Medication Management, Chronic Disease Present | active | 2023-12 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.59 | Findings Related to Medication Management, Taking Medication for Chronic Disease | active | 2017-08 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1219.150 | Fall or Fall Risk from Wheelchair or Scooter ICD10CM | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1219.147 | Mobility Impairment or Fall From Chair ICD10CM | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1219.144 | Bed Confinement Impairment | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.302 | Test Cervical Excision Procedures | active | 2023-10 | ||
hl7.fhir.us.core | R4 | ValueSet/us-core-screening-assessment-observation-maximum-category | US Core Screening Assessment Observation Maximum Category | trial-use | 3 | cgp | 2024-11 |
hl7.fhir.us.core | R4 | ValueSet/us-core-simple-observation-category | US Core Simple Observation Category | trial-use | 3 | cgp | 2024-11 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.11.20.9.87 | Postpartum Status | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.190123 | Diagnostic Mammography Study | active | 2018-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1902 | Ultrasound of the Breast | active | 2019-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.190412 | Screening Mammography and DBT Studies | active | 2018-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.4066 | Diagnostic DBT Study | active | 2022-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.13883.3.3157.4067 | MRI of the Breast | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.13883.3.3157.4068 | MRI of the Breast | active | 2022-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1267.25 | Detailed race including absence reasons. | active | 2025-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.6 | Personal Health Goals LOINC | active | 2024-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.13 | Healthcare Agent Powers or Limitations Indicator | active | 2024-11 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1221.208 | Sexual Orientation | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.264 | CDS Pregnancy | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.265 | CDS Pregnancy Intensional | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.11 | Cirrhosis ICD9CM | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.13 | Cirrhosis SNOMEDCT | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.14 | Cirrhosis | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1221.179 | Abortion Medications | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1221.184 | Letrozole (Aromatase inhibitor) | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.12 | Negative | active | 2023-08 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1095.11 | Nutrition Focused Physical Findings SNOMED CT | active | 2025-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.207 | PharmacyEnvironmentsOfCare | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.205 | PharmacyTypeOfProfession | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.181 | PharmacyEncounterReason | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.197 | PharmacyAllergies | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.198 | PharmacyInterventions | active | 2024-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.200 | PharmacyReasonsForInterventions | active | 2024-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.201 | PharmacyInterventionStatus | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.202 | PharmacyCareCoordination | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.203 | PharmacyReferralsTo | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.204 | PharmacyGoalStatusOutcome | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.208 | PharmacyEncounterType | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.209 | PharmacytEncounterClass | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.211 | PharmacyAllergyIntoleranceType | active | 2018-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.212 | PharmacyAllergyIntoleranceManifestation | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.213 | PharmacyReasonForMedicationChange | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.214 | PharmacyEducation | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.215 | PharmacyEducationStatus | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.216 | PharmacyReferralsFrom | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.7 | Health Goals Grouping | active | 2022-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1221.177 | Mifepristone | active | 2024-04 | ||
hl7.fhir.us.core | R4 | ValueSet/us-core-screening-assessment-observation-category | US Core Screening Assessment Observation Category | trial-use | 3 | cgp | 2024-11 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1248.107 | Mechanical Ventilation | active | 2022-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1248.109 | aPTT Tests | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1248.106 | Mechanical Ventilation | active | 2024-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.96 | Dependence on dialysis | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.117 | Syphilis Tests | active | 2023-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.1.11.20.2.9 | Nutrition Recommendations | active | 2018-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.1.11.15913 | EntityNameUse | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1116.365 | Hospice Care Referral or Admission | active | 2025-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.2 | Abdomen CT with contrast | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.21 | Abdomen CT Without then With Contrast | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1 | Abdomen CT without contrast | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1017 | Adrenal Mass | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1020 | Hematuria | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1021 | Infections of Kidney | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1022 | Jaundice | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1023 | Liver Lesion (Mass or Neoplasm) | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1024 | Malignant Neoplasm of Bladder | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1025 | Malignant Neoplasm of Pancreas | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1026 | Non Traumatic Aortic Disease | active | 2023-11 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1028 | Unspecified Disorder of Kidney and Ureter | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1805 | MRI Lumbar Spine Procedures | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1802 | Physical Therapy | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1812 | Biomechanical Lesions (not Elsewhere Classified) | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1809 | Other Deforming Dorsopathies | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1813 | Dislocation or Sprain of those Joints and Ligaments Located in the Lumbar Spine or Pelvis | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1811 | Other Dorsopathies | active | 2021-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1810 | Spondylopathies | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1803 | Chiropractic Evaluation | active | 2020-07 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.13883.3.3157.4069 | Intraspinal Abscess | active | 2022-09 |